Health Equity: Inclusion of diverse communities in AD/ADRD research

AD-Related Dementias Focus

Advance equity in AD/ADRD research via inclusion science to improve representative sampling and retention of diverse communities.

2027 RFA-NS-25-013: Clinical Trial Readiness to Understand and Develop Solutions to Social, Ethical, Behavioral Implications and Barriers to Health Equity in ADRD (R01 - Clinical Trial Not Allowed) 12.L In Progress DN 2022 ADRD Summit: Health Equity in AD/ADRD, Milestone 1, Priority 1 Blog: Join us March 22 for a webinar on building more inclusive Alzheimer’s studies Workshop: Examining Diversity, Recruitment, and Retention in Alzheimer's Disease (AD) and AD-Related Dementias Research (PDF, 147KB) Recruitment and Citizen Engagement NIA’s Clinical Research Operations & Management System (CROMS) Diverse Vascular Contributions to Cognitive Impairment and Dementia (VCID) Addition of Formative Research Takeaways for Development of OutreachPro Messaging

• Conduct at least one new project to develop new community-based strategies to recruit, retain, and engage study participants from diverse populations.
• Continue to develop, update disseminate, and implement ‘best practice’ resources for AD/ADRD clinical research to increase engagement and retention of diverse patients and caregivers.
• Develop a resource that tracks subject recruitment in clinical trials by gender, race/ethnicity, socioeconomic status, geographic region, and other key features.